MedTrace Logo

COVID-19 Testing in Underserved and Vulnerable Populations

NCT05315908 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9120

Last updated 2024-02-28

Study results available
· View outcomes & findings →

Summary

As part of National Institutes of Health Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) program, the goal of the RADxUP study is to develop, test, and evaluate a rapid, scalable capacity building project to enhance COVID-19 testing in three regional community health centers (CHCs) in San Diego County, California. In collaboration with CHC partners, their consortium organization, Health Quality Partners (HQP), investigators are pursuing the following Specific Aims: 1) Compare the effectiveness of automated calls vs text messaging for uptake of COVID-19 testing among asymptomatic adult patients with select medical conditions and those 65 years of age and older receiving care at participating CHCs. Secondarily, investigators will invite all study participants to receive flu vaccination and will assess feasibility and acceptability of study participants to refer adult family household members who are essential workers for COVID-19 testing. 2) Gather patient, provider, CHC leadership, and community stakeholder insights to establish best practices for future scale-up of COVID-19 testing sustainability and vaccination.

Conditions

Interventions

OTHER

Community outreach method

The method includes automated call and text messaging to increase testing for COVID-19

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Jesse Nodora

    lead OTHER

Principal Investigators

  • Elena Martinez, PhD · Moores Cancer Center, University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-11-15
Completion
2021-11-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05315908 on ClinicalTrials.gov